Dec 6 (Reuters) - Zevra Therapeutics Inc ZVRA.O:
ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGES
ZEVRA THERAPEUTICS INC - CONSOLIDATES DEVELOPMENT AND SCIENTIFIC FUNCTIONS UNDER CMO ADRIAN QUARTEL
ZEVRA THERAPEUTICS INC - ELIMINATES POSITIONS IN CHEMISTRY, MANUFACTURING AND CONTROLS AND CLINICAL DEVELOPMENT
ZEVRA THERAPEUTICS INC - TO CLOSE LABORATORY FACILITIES IN IOWA AND VIRGINIA
ZEVRA THERAPEUTICS INC - ZEVRA HAS DISCONTINUED ITS IN-HOUSE DRUG DISCOVERY ACTIVITIES
ZEVRA THERAPEUTICS INC - CHRISTAL M.M. MICKLE, CHIEF DEVELOPMENT OFFICER, AND SVEN GUENTHER, PH.D., CHIEF SCIENTIFIC OFFICER, TO DEPART CO
Source text: ID:nGNX9N7qYZ
Further company coverage: ZVRA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.